Adverum Biotechnologies (ADVM) Misses Q3 EPS by 130c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q3 EPS of ($1.30). Revenue for the quarter came in at $1 million.

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Nasdaq grants Snail Games conditional listing extension for SNAL stock
• Designer Brands (DBI) PT Lowered to $6 at UBS